The G20 5 Brain Initiative / Neuroscience Summit will be initiated on November 26 - 27, 2018 at Buenos Aires, Argentina within the scope of the collaborative studies on brain mapping. The scientists that conduct researches on the brain will come together at the summit that is supported by Üsküdar University.
The G20 Neuroscience Summit that is organized by the collaboration of Üsküdar University, IBM, Mind Eye Institute and Society for Brain Mapping & Therapeutics (SBMT) will discuss “Reducing Healthcare Costs, Improving Outcome Through Innovation, and Fast Tracking Neurotech Development” this year.
Aside from Argentina; Turkey, Australia, Japan, Canada, Germany, Brazil, America, South Africa, France, Italy, Saudi Arabia, India, Indonesia, China, Mexico, Russia, European Union, South Korea, and the United Kingdom leaders and representatives will attend the G20 Summit. Üsküdar University President Prof. Nevzat Tarhan and Human Resources Director Serdar Karagöz will attend the summit.
The G20 Neuroscience Summit aims to discuss new diagnostic and therapeutic methods for patients with neurosurgical and spinal disorders, and make global consensus as well as partnerships on the brain and spine initiatives.
The G20 Neuroscience Summit aims to gather scientists, engineers, and physicians in order to contribute to the initiative of the former President of the United States Barack Obama (Brain Initiative) within the scope of the summit, increase the actions related to initiatives in the G20 countries, and introduce these studies. The clinical solutions for neurological disorders costing $ 100 billion each year to the world economy are handled within the scope of this summit.
Üsküdar University has been the first and only university to represent Turkey at the G20 Leaders Summit held in Antalya in November 2015 and also attended the summits at China in 2016 and Germany in 2017.
Üsküdar University is the representative of Turkey and project partner of the Brain Initiative Project initiated by the former US President Barack Obama on 2013.
A number of studies have been conducted so far in the context of the project aimed at researching and developing important brain diseases such as autism, schizophrenia, Parkinson's and Alzheimer's as well as unraveling the unknown secrets of the brain.
İletişim Ofisi Public Relations Agency / Ayşegül Erben / email@example.com / +90 212 324 80 17, +90 536 572 27 88